(-)-二盐酸西替利嗪; 2-[2-[4-[(R)-（4-氯苯基）-苯基-甲基]哌嗪-1-基]乙氧基]乙酸二盐酸盐

产品名称：

130018-87-0
Levocetirizine Dihydrochloride
(-)-Cetirizine dihydrochloride; 2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
左西替利嗪二盐酸盐
(-)-二盐酸西替利嗪; 2-[2-[4-[(R)-（4-氯苯基）-苯基-甲基]哌嗪-1-基]乙氧基]乙酸二盐酸盐

产品介绍：

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

生化/生理作用

盐酸左西替利嗪是一种非镇静抗组胺药。它是一种组胺H1受体拮抗剂，西替利嗪的活性异构体。左西替利嗪对H1受体具有较高的生物利用度、高亲和力和占据度。

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式	C₂₁H₂₅ClN₂O₃·2HCl
分子量	461.81
MDL编号	MFCD07366507

产品性质

等级	certified reference material pharmaceutical secondary standard
CofA	current certificate can be downloaded
包装	pkg of 500 mg
application(s)	pharmaceutical
药典可追溯性	traceable to USP 1359969
储存温度	2-8℃
SMILES string	Cl.Cl.OC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3
InChI	1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1
InChI key	PGLIUCLTXOYQMV-GHVWMZMZSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302 - H400
预防措施声明	P264 - P270 - P273 - P301 + P312 - P391 - P501
危险分类	Acute Tox. 4 Oral - Aquatic Acute 1
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable

Levocetirizine Dihydrochloride

左西替利嗪 二盐酸盐

左西替利嗪二盐酸盐